Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Fisher-Price Rock ‘n Play Sleeper Recall Reannounced After Additional Infant Deaths An additional 70 infant deaths have been linked to recalled Fisher-Price Rock ‘n Play Sleepers, which continue to be used by families despite the serious suffocation risks the design poses January 10, 2023 Russell Maas Add Your Comments Federal safety officials have re-announced a Fischer-Price recall that impacted nearly 5 million “Rock ‘n Play” infant sleepers, after receiving dozens of additional reports of infants becoming trapped and suffocating to death against the fabric years after the products were removed from the market. The U.S. Consumer Product Safety Commission (CPSC) posted new information about the Fischer-Price infant sleeper recall on January 9, 2023, warning that many consumers are placing their children’s life at serious risk by continuing to use the recalled inclining sleepers. Infant suffocation risks have been linked to a number of inclined sleeping products sold in recent years, including rockers, gliders, soothers, and swings. However, concerns over the design of Fisher-Price’s Rock ‘n Play sleepers were first raised in early 2019, after the products were linked to at least 30 infant fatalities. According to the latest update, the CPSC has now become aware of an additional 70 infant deaths involving inclining sleeper products. The agency stated that Fisher-Price has been investigating the reported incidents and in some of the cases has been unable to confirm the circumstances or whether the product was a Rock ‘n Play Sleeper. Fischer-Price Rock n’ Play Sleeper Recall In early April 2019, the CPSC first raised concerns over the inclining design of Fischer-Price Rock ‘n Play infant sleepers, warning consumers to stop placing infants in the sleepers before they begin to show signs that they can roll over independently. Officials warned that infants may have the ability to roll over on their stomach and become trapped against the inclined bed, creating a suffocation risk. Shortly after the initial CPSC warning, the American Academy of Pediatrics (AAP) issued a statement, calling for the commission to issue an immediate recall for the Rock’n Play Sleepers. The AAP determined the inclined sleepers were unsafe, and that the CPSC warning did not go far enough to ensure the safety of infants. Just 12 days after the warning, the agency issued a Fisher-Price Rock ‘n Play Sleeper recall, impacting approximately 4.7 million units. The recalled included all models of Rock ‘n Play sleepers that were distributed for sale throughout the United States to major retailers for between $40 and $149 since 2009. BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BABY FORMULA NEC LAWSUITS Was your premature child fed Similac or Enfamil? Premature infants fed Similac or Enfamil cow’s milk formula face an increased risk of necrotizing enterocolitis (NEC) or wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Fischer- Price Rock ‘n Play Lawsuits Following a nearly two year investigation after the recall, a House Oversight Committee report was released in June 2021, alleging Fisher-Price failed to adequately vet the Rock’n Play inclined infant sleeper for safety before putting it on the market in 2009, and indicating the manufacturer intentionally ignored pre-market warnings and concealed reports of infant deaths to avoid issuing costly recalls. The report also revealed Fisher-Price and its parent company, Mattel Inc., were aware of dangers posed by the 30 degree inclining sleepers well before the products were available to consumers. According to the findings, the company’s internal safety committee raised alarms about the dangers posed by an inclined sleeper as early as 2008. According to the report, Fisher-Price had documented at least 14 infant deaths in the sleepers by February 2018, which is more than a year prior to publicly recognizing any potential risks to consumers, and allegedly never reported the deaths to the CPSC. Since the recalls, Fisher-Price has been hit with a number of inclined sleeper individual wrongful death lawsuits and at least 10 class action lawsuits alleging the manufacturer knew or should have known about the risk of problems, yet delayed announcing a recall or warning, and knowingly allowed parents to continue purchasing life-threatening sleeper devices. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Children Furniture Recall, Fisher-Price, Infant Deaths, Infant Sleeper Find Out If You Qualify for Infant Formula NEC Compensation More Baby Formula Lawsuit Stories Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025 Second NEC Baby Formula Bellwether Trial Will Not Move Forward July 29, 2025 Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims July 24, 2025 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: today) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025) Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Second Wave of NEC Formula Lawsuits To Be Prepared for Bellwether Trials in Aug. 2026 October 9, 2025
Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: today) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)